tetano
Editor, Senior Moderator
Virology. 2018 Jul 12;522:65-72. doi: 10.1016/j.virol.2018.07.005. [Epub ahead of print]
[h=1]Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.[/h] Shcherbik S[SUP]1[/SUP], Carney P[SUP]1[/SUP], Pearce N[SUP]2[/SUP], Stevens J[SUP]1[/SUP], Dugan VG[SUP]1[/SUP], Wentworth DE[SUP]1[/SUP], Bousse T[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Cold adapted influenza virus A/Leningrad/134/17/57 (H2N2) is a reliable master donor virus (Len/17-MDV) for preparing live attenuated influenza vaccines (LAIV). LAIVs are 6:2 reasortants that contain 6 segments of Len/17-MDV and the hemagglutinin (HA) and neuraminidase (NA) of contemporary circulating influenza A viruses. The problem with the classical reassortment procedure used to generate LAIVs is that there is limited selection pressure against NA of the Len/17-MDV resulting in 7:1 reassortants with desired HA only, which are not suitable LAIVs. The monoclonal antibodies (mAb) directed against the N2 of Len/17-MDV were generated. 10C4-8E7 mAb inhibits cell-to-cell spread of viruses containing the Len/17-MDV N2, but not viruses with the related N2 from contemporary H3N2 viruses. 10C4-8E7 antibody specifically inhibited the Len/17-MDV replication in vitro and in ovo but didn't inhibit replication of H3N2 or H1N1pdm09 reassortants. Our data demonstrate that addition of 10C4-8E7 in the classical reassortment improves efficiency of LAIV production.
[h=4]KEYWORDS:[/h] Classical reassortment; Influenza; Live vaccine; Monoclonal antibody; Neuraminidase
PMID: 30014859 DOI: 10.1016/j.virol.2018.07.005
[h=1]Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.[/h] Shcherbik S[SUP]1[/SUP], Carney P[SUP]1[/SUP], Pearce N[SUP]2[/SUP], Stevens J[SUP]1[/SUP], Dugan VG[SUP]1[/SUP], Wentworth DE[SUP]1[/SUP], Bousse T[SUP]3[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] Cold adapted influenza virus A/Leningrad/134/17/57 (H2N2) is a reliable master donor virus (Len/17-MDV) for preparing live attenuated influenza vaccines (LAIV). LAIVs are 6:2 reasortants that contain 6 segments of Len/17-MDV and the hemagglutinin (HA) and neuraminidase (NA) of contemporary circulating influenza A viruses. The problem with the classical reassortment procedure used to generate LAIVs is that there is limited selection pressure against NA of the Len/17-MDV resulting in 7:1 reassortants with desired HA only, which are not suitable LAIVs. The monoclonal antibodies (mAb) directed against the N2 of Len/17-MDV were generated. 10C4-8E7 mAb inhibits cell-to-cell spread of viruses containing the Len/17-MDV N2, but not viruses with the related N2 from contemporary H3N2 viruses. 10C4-8E7 antibody specifically inhibited the Len/17-MDV replication in vitro and in ovo but didn't inhibit replication of H3N2 or H1N1pdm09 reassortants. Our data demonstrate that addition of 10C4-8E7 in the classical reassortment improves efficiency of LAIV production.
[h=4]KEYWORDS:[/h] Classical reassortment; Influenza; Live vaccine; Monoclonal antibody; Neuraminidase
PMID: 30014859 DOI: 10.1016/j.virol.2018.07.005